Abstract
Ranbaxy Laboratories has received US FDA approval for the manufacture and marketing of cefuroxime axetil for oral suspension USP
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.2165/00128413-200816250-00063
Journal: Inpharma Weekly | Publication Date: Feb 1, 2008 |
Ranbaxy Laboratories has received US FDA approval for the manufacture and marketing of cefuroxime axetil for oral suspension USP
Join us for a 30 min session where you can share your feedback and ask us any queries you have